These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
80 related items for PubMed ID: 3432825
1. [Catergen-induced immune hemolytic anemia following sensitization by other flavonoids]. Quadri F, Neftel K, Zwahlen H, Marone C. Schweiz Rundsch Med Prax; 1987 Nov 24; 76(48):1338-40. PubMed ID: 3432825 [No Abstract] [Full Text] [Related]
2. [Immunohematologic studies on the correlations between (+)-cyanidanol-3-(catergen) therapy and hemolytic anemia]. Pausch V, Göbel J. Wien Med Wochenschr; 1983 Nov 15; 133(21):559-65. PubMed ID: 6419470 [Abstract] [Full Text] [Related]
3. [Autoimmune hemolysis after Catergen ([+]-cyanidanol-3)]. Neftel K, Fontana A, Guggenheim M, Schenker T, Gmür J, von Felten A, Marti C, Frick PG. Schweiz Med Wochenschr; 1987 Nov 14; 117(46):1824-7. PubMed ID: 3423771 [Abstract] [Full Text] [Related]
14. [Antibodies against mezlocillin and cefonicid in a patient with immune hemolytic anemia]. Romo M, Martín Vega C, Guerra JL, de Diego T. Sangre (Barc); 1991 Aug 30; 36(4):328-9. PubMed ID: 1776113 [No Abstract] [Full Text] [Related]
16. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease. Pár A, Horváth T, Beró T, Kádas I, Pakodi F, Jávor T. Acta Physiol Hung; 1984 Aug 30; 64(3-4):449-54. PubMed ID: 6152369 [Abstract] [Full Text] [Related]
17. [Alcoholic hepatopathy. Aspects of drug therapy]. Del Dotto M, Neri D. G Clin Med; 1982 Apr 30; 63(4):228-36. PubMed ID: 7128979 [No Abstract] [Full Text] [Related]
19. Unexpected immune hemolytic anemia in an intensive care ward patient. Bain BJ, Innes A. Am J Hematol; 2010 Mar 30; 85(3):181. PubMed ID: 19802883 [No Abstract] [Full Text] [Related]